文献速递泌尿生殖妇产影像US

利用光声成像表征附件病变以改进超声O-RADS风险评估

Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessment.
PubMed 文献 · Ultrasound Obstet Gynecol · 2023-01-01

前瞻性研究纳入68例计划行卵巢切除术的女性共93个卵巢/附件病变,在术前进行常规超声及配准光声成像,由两名放射科医生用超声O-RADS分级并计算病变区相对总血红蛋白浓度(rHbT)和血氧饱和度(%sO2)。结果显示rHbT在恶性病变中显著高于良性病变,%sO2在恶性病变中较低但差异未达统计学显著;联合CA125、O-RADS、rHbT和%sO2的模型AUC达0.970,敏感度100%、特异度82%。

要点

  • 光声成像衍生的rHbT在恶性附件病变中显著高于良性病变。
  • 联合CA125、O-RADS、rHbT和%sO2的模型AUC为0.970,敏感度100%、特异度82%。
  • 仅用O-RADS的模型AUC为0.857,加入光声参数后诊断性能提升。

核心结论

  • 整合光声成像衍生的rHbT和%sO2可显著提高超声O-RADS对附件病变的诊断性能。

研究设计与样本

  • 前瞻性研究纳入68例计划行卵巢切除术的女性,共识别93个卵巢/附件病变,术前进行临床超声检查及配准超声与光声成像,由两名放射科医生按超声O-RADS分级,并以组织病理学为参考标准分组比较。

关键影像表现/征象

  • 光声成像计算病变感兴趣区的相对总血红蛋白浓度(rHbT)和血氧饱和度(%sO2)伪彩图。
  • 恶性病变的rHbT显著高于良性病变。
  • 恶性病变的%sO2较低,但与所有良性类别比较差异未达统计学显著。

诊断标准与关键数值

  • CA125单独预测恶性的AUC为0.789(95%CI 0.626-0.953)。
  • 超声O-RADS单独预测恶性的AUC为0.857(95%CI 0.733-0.981)。
  • CA125联合O-RADS的AUC为0.883(95%CI 0.760-1)。
  • rHbT联合%sO2的AUC为0.900(95%CI 0.815-0.985)。
  • 联合CA125、O-RADS、rHbT和%sO2四预测因子的模型AUC为0.970(95%CI 0.932-1),敏感度100%、特异度82%。

临床应用与阅片要点

  • 在超声O-RADS评估附件病变时,可参考光声成像衍生的rHbT和%sO2信息辅助判断恶性风险。
  • 联合CA125、O-RADS、rHbT和%sO2的模型在预测恶性时敏感度100%、特异度82%,AUC为0.970。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To assess the impact of photoacoustic imaging (PAI) on the assessment of ovarian/adnexal lesion(s) of different risk categories using the sonographic ovarian-adnexal imaging-reporting-data system (O-RADS) in women undergoing planned oophorectomy.

METHOD: This prospective study enrolled women with ovarian/adnexal lesion(s) suggestive of malignancy referred for oophorectomy. Participants underwent clinical ultrasound (US) examination followed by coregistered US and PAI prior to oophorectomy. Each ovarian/adnexal lesion was graded by two radiologists using the US O-RADS scale. PAI was used to compute relative total hemoglobin concentration (rHbT) and blood oxygenation saturation (%sO2 ) colormaps in the region of interest. Lesions were categorized by histopathology into malignant ovarian/adnexal lesion, malignant Fallopian tube only and several benign categories, in order to assess the impact of incorporating PAI in the assessment of risk of malignancy with O-RADS. Malignant and benign histologic groups were compared with respect to rHbT and %sO2 and logistic regression models were developed based on tumor marker CA125 alone, US-based O-RADS alone, PAI-based rHbT with %sO2 , and the combination of CA125, O-RADS, rHbT and %sO2. Areas under the receiver-operating-characteristics curve (AUC) were used to compare the diagnostic performance of the models.

RESULTS: There were 93 lesions identified on imaging among 68 women (mean age, 52 (range, 21-79) years). Surgical pathology revealed 14 patients with malignant ovarian/adnexal lesion, two with malignant Fallopian tube only and 52 with benign findings. rHbT was significantly higher in malignant compared with benign lesions. %sO2 was lower in malignant lesions, but the difference was not statistically significant for all benign categories. Feature analysis revealed that rHbT, CA125, O-RADS and %sO2 were the most important predictors of malignancy. Logistic regression models revealed an AUC of 0.789 (95% CI, 0.626-0.953) for CA125 alone, AUC of 0.857 (95% CI, 0.733-0.981) for O-RADS only, AUC of 0.883 (95% CI, 0.760-1) for CA125 and O-RADS and an AUC of 0.900 (95% CI, 0.815-0.985) for rHbT and %sO2 in the prediction of malignancy. A model utilizing all four predictors (CA125, O-RADS, rHbT and %sO2 ) achieved superior performance, with an AUC of 0.970 (95% CI, 0.932-1), sensitivity of 100% and specificity of 82%.

CONCLUSIONS: Incorporating the additional information provided by PAI-derived rHbT and %sO2 improves significantly the performance of US-based O-RADS in the diagnosis of adnexal lesions. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Zhu Q, Luo H, Middleton WD, et al. Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessment. Ultrasound Obstet Gynecol. 2023. PMID: 37606287. doi:10.1002/uog.27452

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。